These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 17023785)
1. Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data. Airoldi M; Cattel L; Passera R; Pedani F; Delprino L; Micari C Am J Clin Oncol; 2006 Oct; 29(5):490-4. PubMed ID: 17023785 [TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data. Airoldi M; Cattel L; Passera R; Pedani F; Milla P; Zanon C Pancreas; 2006 Jan; 32(1):44-50. PubMed ID: 16340743 [TBL] [Abstract][Full Text] [Related]
3. The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study. Morabito A; Filippelli G; Palmeri S; Cascinu S; Ferraù F; Zagonel V; Gattuso D; Catalano V; Capaccetti B; Franciosi V; Accurso V; Scinto F; Gasparini G Breast Cancer Res Treat; 2003 Mar; 78(1):29-36. PubMed ID: 12611454 [TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patients. Caruba T; Cottu PH; Madelaine-Chambrin I; Espié M; Misset JL; Gross-Goupil M Breast J; 2007; 13(2):165-71. PubMed ID: 17319858 [TBL] [Abstract][Full Text] [Related]
5. Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens. Sánchez-Escribano Morcuende R; Alés-Martínez JE; Aramburo González PM Clin Transl Oncol; 2007 Jul; 9(7):459-64. PubMed ID: 17652060 [TBL] [Abstract][Full Text] [Related]
6. Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes. Andres R; Mayordomo JI; Lara R; Lastra R; Ortega E; Polo E; Lambea J; Isla D; Saenz-Cusi A; Escudero P; Tres A Clin Breast Cancer; 2005 Jun; 6(2):158-62. PubMed ID: 16001994 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer. Petit T; Benider A; Yovine A; Bougnoux P; Spaeth D; Maindrault-Goebel F; Serin D; Tigaud JD; Eymard JC; Simon H; Bertaux B; Brienza S; Cvitkovic E Anticancer Drugs; 2006 Mar; 17(3):337-43. PubMed ID: 16520663 [TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study. Pectasides D; Pectasides M; Farmakis D; Bountouroglou N; Nikolaou M; Koumpou M; Mylonakis N; Kosmas C Ann Oncol; 2003 Apr; 14(4):537-42. PubMed ID: 12649097 [TBL] [Abstract][Full Text] [Related]
9. An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes. Awada A; Biganzoli L; Cufer T; Beex L; Lohrisch C; Batter V; Hamilton A; Nooij M; Piccart M Eur J Cancer; 2002 Apr; 38(6):773-8. PubMed ID: 11937310 [TBL] [Abstract][Full Text] [Related]
10. A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. Karachaliou N; Kouroussis Ch; Papakotoulas P; Kalbakis K; Tryfonidis K; Vardakis N; Poppis E; Georgoulias V; Mavroudis D Cancer Chemother Pharmacol; 2012 May; 69(5):1345-52. PubMed ID: 22349809 [TBL] [Abstract][Full Text] [Related]
11. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes. Chan D; Yeo WL; Tiemsim Cordero M; Wong CI; Chuah B; Soo R; Tan SH; Lim SE; Goh BC; Lee SC Invest New Drugs; 2010 Dec; 28(6):859-65. PubMed ID: 19705063 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients. Sun S; Wang LP; Zhang J; Yang XY; Zhang QL; Jia Z; Hu XC; Wang BY Med Oncol; 2012 Jun; 29(2):418-24. PubMed ID: 21298496 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients. Zelek L; Cottu P; Tubiana-Hulin M; Vannetzel JM; Chollet P; Misset JL; Chouaki N; Marty M; Gamelin E; Culine S; Dieras V; Mackenzie S; Spielmann M J Clin Oncol; 2002 May; 20(10):2551-8. PubMed ID: 12011135 [TBL] [Abstract][Full Text] [Related]
15. A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Campone M; Isambert N; Bourbouloux E; Roché H; Bonneterre J; Milano G; Fumoleau P Cancer Chemother Pharmacol; 2012 Apr; 69(4):871-9. PubMed ID: 22045498 [TBL] [Abstract][Full Text] [Related]
16. Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial. Gioulbasanis I; Saridaki Z; Kalykaki A; Vamvakas L; Kalbakis K; Ignatiadis M; Amarantidis K; Kakolyris S; Georgoulias V; Mavroudis D Anticancer Res; 2008; 28(5B):3019-25. PubMed ID: 19031950 [TBL] [Abstract][Full Text] [Related]
17. Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes. Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V Br J Cancer; 2001 Sep; 85(6):798-802. PubMed ID: 11556827 [TBL] [Abstract][Full Text] [Related]
18. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. Martín M; Ruiz A; Muñoz M; Balil A; García-Mata J; Calvo L; Carrasco E; Mahillo E; Casado A; García-Saenz JA; Escudero MJ; Guillem V; Jara C; Ribelles N; Salas F; Soto C; Morales-Vasquez F; Rodríguez CA; Adrover E; Mel JR; Lancet Oncol; 2007 Mar; 8(3):219-25. PubMed ID: 17329192 [TBL] [Abstract][Full Text] [Related]
19. Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group. Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V Ann Oncol; 1999 Feb; 10(2):211-5. PubMed ID: 10093691 [TBL] [Abstract][Full Text] [Related]
20. High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer. Heinemann V; Stemmler HJ; Wohlrab A; Bosse D; Losem C; Kahlert S; Rauthe G Cancer Chemother Pharmacol; 2006 May; 57(5):640-6. PubMed ID: 16163537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]